Breaking News

CordenPharma Acquires Pfizer API Mfg. Facility

54,000 square foot facility has production capabilities ranging from very small-scale up to 3,000 liters

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CordenPharma, a contract development and manufacturing organization (CDMO), has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer, Inc. The closing of the transaction is anticipated to occur in November 2017. Located in proximity to the existing CordenPharma Colorado facility, Hospira Boulder produces active pharmaceutical ingredients (APIs) and intermediate products with specialized capabilities in small to medium scale hi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters